Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Jul 17;5(9):a021535.
doi: 10.1101/cshperspect.a021535.

Treatment of Liver Cancer

Chun-Yu Liu  1 , Kuen-Feng Chen  2 , Pei-Jer Chen  3
Affiliations
Review

Treatment of Liver Cancer

Chun-Yu Liu et al. Cold Spring Harb Perspect Med. .

Abstract

Primary liver cancer, mostly hepatocellular carcinoma, remains a difficult-to-treat cancer. Incidence of liver cancer varies geographically and parallels with the geographic prevalence of viral hepatitis. A number of staging systems have been developed, reflecting the heterogeneity of primary liver cancer, regional preferences, and regional variations in resectability or transplant eligibility. Multimodality treatments are available for this heterogeneous malignancy, and there are variations in the management recommendations for liver cancers across specialties and geographic regions. Novel treatment strategies have merged with the advance of new treatment modalities. This work focuses on reviewing the incidence, staging, and treatment of liver cancer.

PubMed Disclaimer

References

    1. Abdalla EK, Hicks ME, Vauthey JN. 2001. Portal vein embolization: Rationale, technique and future prospects. Br J Surg 88: 165–175. - PubMed
    1. Abulkhir A, Limongelli P, Healey AJ, Damrah O, Tait P, Jackson J, Habib N, Jiao LR. 2008. Preoperative portal vein embolization for major liver resection: A meta-analysis. Ann Surg 247: 49–57. - PubMed
    1. Altekruse SF, McGlynn KA, Reichman ME. 2009. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol 27: 1485–1491. - PMC - PubMed
    1. Altekruse SF, McGlynn KA, Dickie LA, Kleiner DE. 2012. Hepatocellular carcinoma confirmation, treatment, and survival in surveillance, epidemiology, and end results registries, 1992–2008. Hepatology 55: 476–482. - PMC - PubMed
    1. Bosetti C, Levi F, Boffetta P, Lucchini F, Negri E, La Vecchia C. 2008. Trends in mortality from hepatocellular carcinoma in Europe, 1980–2004. Hepatology 48: 137–145. - PubMed

MeSH terms

Substances